title: Bone mineral loss in young women with amenorrhoea.
abstract: OBJECTIVE
  To examine the impact of amenorrhoea on bone mineral density in women of reproductive age.
  
  
  METHODS
  Cross sectional study of 200 amenorrhoeic women compared with normally menstruating controls.
  
  
  METHODS
  Teaching hospital outpatient clinic specialising in reproductive medicine.
  
  
  METHODS
  200 Women aged 16-40 with a past or current history of amenorrhoea from various causes and of a median duration of three years, and a control group of 57 age matched normal volunteers with no history of menstrual disorder.
  
  
  METHODS
  Bone mineral density in the lumbar spine (L1-L4) as measured by dual energy x ray absorptiometry.
  
  
  RESULTS
  The amenorrhoeic group showed a mean reduction in bone mineral density of 15% (95% confidence interval 12% to 18%) as compared with controls (mean bone mineral density 0.89 (SD 0.12) g/cm2 v 1.05 (0.09) g/cm2 in controls). Bone loss was related to the duration of amenorrhoea and the severity of oestrogen deficiency rather than to the underlying diagnosis. Patients with a history of fracture had significantly lower bone density than those without a history of fracture. Ten patients had suffered an apparently atraumatic fracture.
  
  
  CONCLUSIONS
  Amenorrhoea in young women should be investigated and treated to prevent bone mineral loss. Menopausal women with a past history of amenorrhoea should be considered to be at high risk of osteoporosis.
authors.affiliation: Middlesex Hospital, London.
authors.forename: M C
authors.initials: MC
authors.lastname: Davies
authors.forename: M L
authors.initials: ML
authors.lastname: Hall
authors.forename: H S
authors.initials: HS
authors.lastname: Jacobs
mesh_terms: D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000150:complications / Q000503:physiopathology*; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D003430:Cross-Sectional Studies; D004967:Estrogens / Q000172:deficiency / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D012907:Smoking; D013997:Time Factors
chemical_list: D004967:Estrogens